Meeting Information Scientific Program Registration Hyatt Regency Hotel Abstract Submission Student and Postdoctoral Fellow Sponsors Exhibitors Monterey


Previous Tuesday
Wednesday, July 2, 2008

7:00 AM–8:00 AM             PUBLIC AFFAIRS COMMITTEE MEETING—Spyglass 2


7:30 AM–2:00 PM             REGISTRATION—Regency Foyer

7:30 AM–8:00 AM             COFFEE AND CONTINENTAL BREAKFAST—Regency Foyer

8:00 AM–10:00 AM            PLATFORM SESSION V—Regency 1
Risk Factors for Adverse Birth Outcomes From Medications to the Environment
Chairpersons: George P. Daston, Procter & Gamble Company and Janet R. Hardy, University of Massachusetts Medical School

8:00 AM–8:15 AM   36   Use of Clomiphene Citrate and Selected Major Birth Defects: Data from the National Birth Defects Prevention Study, U.S.A. 1997–2004
Reefhuis J1, Honein MA1, Schieve LA1, Correa A1, Hobbs CA2, Rasmussen SA1. 1NCBDDD, CDC, Atlanta, GA, United States, 2University of Arkansas for Medical Sciences, Little Rock, AR, United States.
8:15 AM–8:30 AM   37   The Effect of Some Cardiac Ion Channel Blockers of the Rat Embryonic Heart In Vitro
Abela D, Webster WS, Ritchie HE, Gavin C, Karlsson K. The University of Sydney, Sydney, Australia.
8:30 AM–8:45 AM   38   Opioid Analgesic Treatment During Pregnancy and Adverse Fetal Outcomes: Results from the National Birth Defects Prevention Study, 1997–2003
Broussard CS1, Reefhuis J1, Friedman JM2, Rasmussen SA1, Jann MW3, Honein MA1. 1Centers for Disease Control and Prevention, Atlanta, GA, United States, 2University of British Columbia, Vancouver, BC, Canada, 3Mercer University, Atlanta, GA, United States.
8:45 AM–9:00 AM   39   Fetal Outcome of Congenital Toxoplasmosis is Improved With Maternal Immune Stimulation
Hrubec TC1,2, Chavan V2, Lindsay DS2, Holladay SD1. 1E. Via Virginia College of Osteopathic Medicine, Blacksburg, VA, United States, 2VA-MD Regional College of Veterinary Medicine, Virginia Tech, Blacksburg, VA, United States.
9:00 AM–9:15 AM   40   Maternal Febrile Illnesses and Risk for Congenital Heart Defects: Findings from the National Birth Defects Prevention Study
Botto LD1, Bishop Stone M1, Browne ML2, Feldkamp ML1, Lammer E3, Shaw GM4, National Birth Defects Prevention Study5. 1Dept Pediatrics/ Medical Genetics, University of Utah, Salt Lake City, UT, United States, 2New York State Department of Health, Troy, NY, United States, 3Oakland Children’s Hospital, Oakland, CA, United States, 4March of Dimes California Research Division, Oakland, Berkeley, CA, United States, 5National Birth Defects Prevention Study, Atlanta, GA, United States.
9:15 AM–9:30 AM   41   Pregnancy Registries: Larger Sample Sizes Essential
Holmes LB1,2, Smith CR1,2, Hernandez-Diaz S1,3. 1North American AED Pregnancy Registry, Boston, MA, United States, 2Genetics Unit, MassGeneral Hospital for Children, Boston, MA, United States, 3Harvard School of Public Health, Boston, MA, United States.
9:30 AM–9:45 AM   42   Placental and Neural Tube Defects After Maternal Fumonisin or FTY720 Exposure: Role of Bioactive Sphingolipids
Gelineau-van Waes J1, Maddox J1, Wilberding J1, Voss K2, Riley R2. 1University of Nebraska Medical Center, Omaha, NE, United States, 2USDA-ARS Toxicology & Mycotoxin Research Unit, Athens, GA, United States.
9:45 AM–10:00 AM   43   EPA’s Endocrine Disruptors Programs: Research Used in Agency Decision-Making
Francis EZ1, Timm G1, Laessig S1, Bayne E2. 1US Environmental Protection Agency, Washington, DC, United States, 2American Schools of Public Health, Washington, DC, United States.

Chairpersons: Dana L. Shuey, Endo Pharmaceuticals, Inc. and Jane Stewart, AstraZeneca Pharmaceuticals

8:00 AM–8:25 AM   S31   The Risks and Benefits of the Immunization Pregnant Women and Women of Reproductive Age: The Risk of Doing Nothing
Speaker: Robert L. Brent, Alfred I. duPont Hospital for Children
8:25 AM–8:50 AM   S32   Nonclinical Testing: Designing Animal Studies to Assess Vaccine Safety in Pregnancy
Speaker: Sarah Gould, Sanofi Pasteur
8:50 AM–9:15 AM   S33   Regulatory Considerations Pertaining to Maternal Immunization
Speaker: Marion F. Gruber, Office of Vaccines Research and Review, U.S. FDA/CDER
9:15 AM–9:40 AM   S34   Case Study: Influenza Vaccine and Its Use During Pregnancy
Speaker: Sonja A. Rasmussen, Centers for Disease Control
9:40 AM–10:00 AM       Panel Discussion

10:00 AM–10:30 AM             WARKANY TEA—Regency Foyer

10:30 AM–12:15 PM             PLATFORM SESSION VI—Regency 1
Research Methods Update >From Laboratory to the Clinic
Chairpersons: Edward W. Carney, The Dow Chemical Company and Wafa A. Harrouk, U.S. Food and Drug Administration

10:30 AM–10:45 AM   44   Maternal and Fetal Toxicity in Developmental Toxicology Bioassays: Weight Changes and Their Biological Significance
Chernoff N, Rogers EH, Gage MI. U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.
10:45 AM–11:00 AM   45   Reduced Water Intake: Implications for Rodent Developmental and Reproductive Toxicity Studies
Campbell MA1, Golub MS2, Iyer P2, Kaufman FL2, Li LH2, Moran F2, Morgan JE2, Donald JM2. 1Office of Environmental Health Hazard Assessment, Cal/EPA, Oakland, CA, United States, 2Office of Environmental Health Hazard Assessment, Cal/EPA, Sacramento, CA, United States.
11:00 AM–11:15 AM   46   EKG-Gated Echocardiography in the Developing Chick Embryo Heart
Schellpfeffer MA, Kolesari GL. Medical College of Wisconsin, Milwaukee, WI, United States.
11:15 AM–11:30 AM   47   Knowledge Base for v-Embryo: Information Infrastructure for In Silico Modeling
Singh AV2, Shah I1, Kavalock RJ1, Knudsen TB1. 1National Center for Computational Toxicology, Office of Research and Development, USEPA, Research Triangle Park, NC, United States, 2Lockheed Martin, Research Triangle Park, NC, United States.
11:30 AM–11:45 AM   48   Recruitment of an Unexposed Control Group for a Pregnancy Registry
Smith CR, Holmes LB. North American AED Pregnancy Registry, Genetics Unit, MassGeneral Hospital for Children, Boston, MA, United States.
11:45 AM–12:00 Noon   49   Application of Micro-Computed Tomography in Rat Teratology Studies
Johnson K1, Davis J2, Ryan L3, Moser G2. 1NIEHS, Research Triangle Park, NC, United States, 2IntegratedLaboratory Inc., Durham, NC, United States, 3HistoMax, Durham, NC, United States.
12:00 NOON–12:15 PM   50   Using Drink Size to Talk About Drinking During Pregnancy: A Randomized Clinical Trial of Early Start Plus
Armstrong MA1, Kaskutas LA2, Witbrodt J2, Taillac C1, Hung YY1, Osejo V1, Escobar G1. 1Kaiser Permanente, Oakland, CA, United States, 2Alcohol Research Group, Emeryville, CA, United States.

10:30 AM–12:30 PM             RARE DISEASES SYMPOSIUM—Regency Main Ballroom
Vascular Disruption Pathogenesis for Selected Birth Defects
Chairperson: Martha M. Werler, Slone Epidemiology Center at Boston University

10:30 AM–11:00 AM   S35   Vascular Disruption Defects: Embryology and Clinical Observations
Speaker: Margot Van Allen, University of British Columbia
11:00 AM–11:30 AM   S36    Free Radical Participation in Vascular Disruption
Speaker: Alan G. Fantel, University of Washington
11:30 AM–12:00 NOON   S37    Epidemiologic Evidence of Vasoactive Exposures Contributing to the Development of Vascular Disruption Defects
Speaker: Martha M. Werler, Slone Epidemiology Center at Boston University
12:00 NOON–12:30 PM   S38   Genetic Risk Factors for Vascular Compromise in Fetal Development
Speaker: Edward J. Lammer, Children’s Hospital Oakland Research Institute

12:30 PM–1:30 PM            LUNCH ON OWN

1:30 PM–4:30 PM             WILEY-LISS SYMPOSIUM—Regency Main Ballroom
Left-Right Patterning
Organized by the Publications Committee: Mark E. Hurtt, Chairperson

1:30 PM–1:35 PM   S39   Opening Remarks
Speaker: Nigel Brown, St. George’s University Hospital
1:35 PM–2:10 PM   S40   Introduction to the Embryologic Basis of Left-Right Asymmetry: It’s All Happening at the Node!
Speaker: Gary Schoenwolf, University of Utah
2:10 PM–2:45 PM   S41   Zebrafish Models of Left-Right Asymmetry
Speaker: Didier Stanier, University of California, San Francisco
2:45 PM–3:00 PM       Break
3:00 PM–3:35 PM   S42   Interspecies Comparisons
Speaker: H. Joseph Yost, University of Utah
3:35 PM–4:10 PM   S43   Human Heterotaxy Syndromes
Speaker: John W. Belmont, Baylor College of Medicine
4:10 PM–4:30 PM      Panel Discussion
Moderator: Nigel Brown, St. George’s University Hospital

4:30 PM–6:00 PM             BUSINESS MEETING AND REPORTS FROM BDR EDITORS—Regency Main Ballroom

6:30 PM–7:30 PM             RECEPTION—Monterey Terrace

7:30 PM–10:00 PM             BANQUET—Monterey Grand Ballroom





Rev. Thursday, April 3, 2008; at 6:04:03 PM EST

Teratology Home Page